D.E. Shaw & Co

D.E. Shaw & Co’s NovoCure NVCR Stock Holding History

D.E. Shaw & Co’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,700	Closed	-$281K	–	5029
2022 Q3	$281K	Buy	+3,700	New	+$289K	﹤0.01%	4327
2021 Q3	–	Sell	-10,000	Closed	-$2.22M	–	5140
2021 Q2	$2.22M	Hold	10,000	–	–	﹤0.01%	2839
2021 Q1	$1.32M	Sell	10,000 -10,900	-52%	-$1.72M	﹤0.01%	2899
2020 Q4	$3.62M	Buy	20,900 +10,900	+109%	+$1.49M	﹤0.01%	2120
2020 Q3	$1.11M	Hold	10,000	–	–	﹤0.01%	2790
2020 Q2	$593K	Hold	10,000	–	–	﹤0.01%	3248
2020 Q1	$673K	Hold	10,000	–	–	﹤0.01%	3030
2019 Q4	$843K	Buy	+10,000	New	+$807K	﹤0.01%	3094

Other funds holding NVCR

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return